EVALUATION OF REAL-WORLD RESPONSE RATE IN CLINICAL TRIAL-ALIGNED COHORTS OF PATIENTS WITH LUNG, COLON, AND BREAST CANCER USING MACHINE LEARNING

被引：0
|
作者：
Zhang, Q. [1 ]
Krismer, K. [2 ]
Wang, X. [2 ]
Fullerton, C. [2 ]
Dolor, A. [2 ]
Wade, N. B. [2 ]
Baruah, P. [2 ]
Yim, E. [2 ]
Williams, T. [2 ]
Yuan, Q. [2 ]
Wilkinson, S. [2 ]
Nemeth, S. [2 ]
Singh, N. [2 ]
Wang, M. [2 ]
Richey, M. [2 ]
Cohen, A. B. [2 ]
Fidyk, E. [2 ]
Blarre, A. [2 ]
Magee, K. [2 ]
机构：
[1] Flatiron Hlth, Jersey City, NJ USA
[2] Flatiron Hlth, New York, NY USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MSR79
引用
收藏
页码：S274 / S274
页数：1
相关论文
共 50 条
  • [31] Using Response Evaluation Criteria in Solid Tumors in real-world evidence cancer research
    Feinberg, Bruce A.
    Bharmal, Murtuza
    Klink, Andrew J.
    Nabhan, Chadi
    Phatak, Hemant
    FUTURE ONCOLOGY, 2018, 14 (27) : 2841 - 2848
  • [32] Assessing the representativeness of trial populations for contemporary real-world cancer patients: A case study of adjuvant chemotherapy for colon cancer
    Lund, Jennifer Leigh
    Webster-Clark, Michael
    Bratton, Emily W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [33] Clinical trial representativeness and treatment intensity in a real-world sample of women with early stage breast cancer
    Gabrielle B. Rocque
    Nicole E. Caston
    Jeffrey A. Franks
    Courtney P. Williams
    Monica S. Aswani
    Andres Azuero
    Risha Gidwani
    Breast Cancer Research and Treatment, 2021, 190 : 531 - 540
  • [34] Evaluation of Real-World Clinical Use of a Blood-Based Colorectal Cancer Screening Test Using a Real-World Evidence Platform
    Forbes, Shaun P.
    Raymond, Victoria
    Zhang, Nicole
    Das, Amar K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S141 - S141
  • [35] Clinical trial representativeness and treatment intensity in a real-world sample of women with early stage breast cancer
    Rocque, Gabrielle B.
    Caston, Nicole E.
    Franks, Jeffrey A.
    Williams, Courtney P.
    Aswani, Monica S.
    Azuero, Andres
    Gidwani, Risha
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (03) : 531 - 540
  • [36] Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design
    Xu, Jie
    Zhang, Hao
    Zhang, Hansi
    Bian, Jiang
    Wang, Fei
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [37] Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design
    Jie Xu
    Hao Zhang
    Hansi Zhang
    Jiang Bian
    Fei Wang
    Scientific Reports, 13 (1)
  • [38] Comparison of response from RECIST1.1 and abstraction in real-world patients with lung cancer
    Chen, Lu
    Davis, Ryan
    Lee, Joe
    Weberpals, Janick
    Wyatt, Shelby
    Ounadjela, Souhila
    Trinh, Huong
    Fruechtenicht, Charlotta
    Reyes, Adriana
    Huntley, Melanie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data
    Liu, Qi
    Zhang, Chenan
    Huang, Yue
    Huang, Ruihao
    Huang, Shiew-Mei
    Larkins, Erin
    Stapleford, Liza
    Rivera, Donna R.
    Kluetz, Paul G.
    Wang, Shenggang
    Zhu, Hao
    Weese, James
    Cromartie, Elizabeth
    Teka, Mahder
    Walters, Sheetal
    Wolf, Frank
    Brown, Thomas D.
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (02): : 258 - 266
  • [40] Real-World Eligibility for Clinical Trials in Extensive Stage Small Cell Lung Cancer Patients
    Dehar, N.
    Meem, M.
    Aggarwal, I.
    Hopman, W.
    Gaudreau, P. -O.
    Robinson, A.
    Fung, A. S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S547 - S547
12345